Skip to main content
. 2022 May 12;23(10):5408. doi: 10.3390/ijms23105408
AD Alzheimer’s disease
α2-AR α2-adrenoceptors
BBB blood−brain barrier
Cl plasma clearance
Cmax maximum observed concentration
HLM human liver microsomes
I2-IR imidazoline I2 receptors
LPS bacterial lipopolysaccharide
MLM mouse liver microsomes
MRM reaction monitoring mode
ND neurodegenerative diseases
6-OHDA 6-hydroxydopamine
PAMPA parallel artificial membrane permeability assay
PD Parkinson’s disease
PK pharmacokinetics
SAMP8 senescence-accelerated mouse prone 8